contatti con gli investitori in materia di salute / cellule staminali campo della terapia necessaria per il finanziamento di clinica medica.

La nostra tecnologia cellule staminali ha raggiunto di recente un successo clinico.

$550k necessaria per romanzo cellule staminali clinica.

2-pagina di carta bianca / 10-page investor deck is complete and professionally done.

Extremely strong science and over 15 years in stem cells medicine.

An extremely rare opportunity for a new Stem Cells technology solving an unmet need in a multi-billion dollar space.


Serious Investors are currently being sought for investment discussions with a trusted, UK-based, clinical research company looking to raise capital for continued research into a very promising areas.
Confidentiality is assured, and any interested parties would be invited to sign a confidentiality agreement before being shown data about the project.

Please email NBScience limited at the addresses below, who will put any interested parties directly in touch with this unique clinical research company.


Karen Williams (Investor Relations Director):

About NBScience:

Established in the year 2004, NBScience limited is one of the leading organizers of medical conferences on a global basis. The main office of this premier UK based company is located in London. Backed y a strong and competent team, this company produces some of the most focused and perfectly executed conferences around the world.

Stabilito in 2004, NBScience sede a Londra, Regno Unito

with seven branch offices worldwide specializes in regulatory affairs,

gestione degli studi clinici, organizzazione conferenza medica, ricerca clinica,

GCP, PIL, GMP certificazione e audit, gestione dei dati,

consulenza farmaceutica e servizi di scrittura medici.

per farmaceutica, biotecnologia, droga generica, e dispositivi medici

aziende di ogni dimensione in tutto il mondo, NBScience può aiutare a trasformare

promettenti idee in realtà commerciale.


terapia con cellule staminali